Bexacat™ (Bexagliflozin) Tablets

15 mg, 90/Bottle

ELANCO ANIMAL HEALTH
Manufacturer Item #:CA5315090AM
Patterson Item #:07-894-8410
Package Quantity: 90/Pkg Brand: Bexacat™ Active Ingredient: Bexagliflozin Volume: 15 mg
See My Price
Quantity
Choose a comparable product or call 1-800-225-7911 for assistance
Overview
Product Specifications
Additional Resources

Bexacat™ (bexagliflozin tablets) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. Download the Patient Selection and Monitoring sheet to help you choose the right patients to prescribe Bexacat and understand the treatment monitoring guidelines.

  • Sodium-glucose cotransporter 2 (SGLT2) inhibitor, this first-in-class therapeutic is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin
  • For oral use in cats only
  • Minimal risk of hypoglycemia and no dosage changes during treatment
  • Convenient, needle-free, once-daily flavored tablet ensures dosing certainty
  • No dose titration needed
  • No refrigeration required
  • Can be given with or without food

Package Quantity: 90/Pkg Brand: Bexacat™ Active Ingredient: Bexagliflozin Volume: 15 mg Presentation: Tablet NDC Number: 58198-5315-02 Container Type: Bottle Delivery Type: Oral Flavor: Beef Product Type: Non-Insulin Oral Medication Pill Count: 90 Reconstitution Required: N NDC Number: 58198-5315-02